LGM
CERE
Logos Global Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-700,000
| Closed | -$15.3M | – | 68 |
|
|
2023
Q3 | $15.3M | Buy |
+700,000
| New | +$15.3M | 2.04% | 17 |
|
|
2023
Q1 | – | Sell |
-260,000
| Closed | -$8.2M | – | 50 |
|
|
2022
Q4 | $8.2M | Buy |
+260,000
| New | +$8.2M | 0.96% | 28 |
|
|
2021
Q1 | – | Sell |
-100,000
| Closed | -$1.66M | – | 75 |
|
|
2020
Q4 | $1.66M | Buy |
+100,000
| New | +$1.66M | 0.14% | 54 |
|